Affibody And UCB Eye Humira’s Weak Spot In Hidradenitis Suppurativa

Following Positive R&D Milestones

 
• By Ayisha Sharma
New Biologic Candidates For HS Could Challenge AbbVie's Humira • Source: Shutterstock

More from Clinical Trials

More from R&D